The AEROECLIPSE* II BAN* Nebulizer:
- Ideal for short-term acute care use
- Single patient, reusable for 7 days
- Can be used with a mouthpiece or mask (mask sold separately)
- Package includes one AEROECLIPSE* II BAN* Nebulizer with mouthpiece, EZ TWIST Tubing and instructions for use
- Asthma Management
- Bronchiectasis
- COPD
- Cystic Fibrosis
- Nebulized Medication
Product Overview
Breath Actuated Delivery
With breath actuated delivery, aerosol is only produced when you breathe in. This means medication is not wasted between breaths or if you need to take a break (for example if you need to cough or have a conversation). This puts you in control of your aerosol treatment. Other nebulizers continuously produce aerosol regardless of whether you are inhaling, exhaling or resting, resulting in medication being lost to the air instead of delivered to your lungs.
Learn more about the difference breath actuated delivery can make!
Features
Designed with patients in mind
- Green feedback button moves down as you inhale to encourage slow, deep breath
- Mouthpiece can be removed and replaced with a mask
- Exhalation Valve directs exhaled breath away from your face and eyes
- Disassembles into just 4 parts for easy cleaning
Combined Aerosol and Oscillating Positive Expiratory Pressure (OPEP) Therapy
The AEROECLIPSE* II BAN* Nebulizer can be connected directly to the AEROBIKA* Oscillating Positive Expiratory Pressure (OPEP) device for nebulizer therapy during inhalation with mucus mobilization during exhalation. Combined treatment could reduce the time needed for the patient to take both treatments separately. Speak to your healthcare provider for more information on combination therapy.
Download the AEROBIKA* OPEP device instructions for information on how to use the device with the AEROECLIPSE* II BAN* Nebulizer.
How to Use in Hospital
- Ensure the exhalation valve on the mouthpiece faces down.
- Inhale and exhale through the mouthpiece to verify the movement of the green feedback button on the top of the nebulizer.
- Unscrew and remove the top of the nebulizer. Place prescribed medication into the nebulizer cup. Reattach the top and gently hand tighten.
- Attach one end of the tubing to the fitting in the bottom of the nebulizer and the other end to the flowmeter or compressed air source. Ensure both ends are securely attached.
- Set the flowmeter to 7 to 8 L/min with a compressed air source capable of delivering 345 kPa (50 psi).
- Place the mouthpiece in mouth, and inhale slowly and deeply. As you inhale, the green feedback button will move into the down position. This indicates the nebulizer is producing aerosol. Exhale normally.
- Continue to inhale from the nebulizer until it starts to sputter.
- Turn off the compressed air source.
Cleaning Methods (excluding tubing)
- Handwashing
- Sterile Water
Disinfection Methods (excluding tubing)
- 70% isopropyl alcohol
- Cidex†
The AEROECLIPSE* II BAN* Nebulizer should be replaced after 7 days of use. Refer to the instructions for use for additional information.
Model Comparison Chart
Consult with your healthcare professional to determine which product is right for you.
| AEROECLIPSE* XL BAN* Nebulizer 
| |
| When to use | Short-term acute care use | For use with a compressor |
| Single Patient, Multiple Use | Use up to 7 days | Use up to 6 months |
| Multiple-Patient Use |
| Use up to 6 months |
| Spontaneous Breathing |
|
|
| Breath Actuated or Continuous Mode |
|
|
| Use with Mouthpiece or Mask |
|
|
| 1mL - 6mL Fill Volume |
|
|
| Cleaning Methods (excluding tubing) |
|
|
| Disinfection methods (excluding tubing)‡ |
|
|
| Autoclavable (excluding tubing)‡‡ |
|
|
The nebulizer (excluding the tubing) can be cleaned after each use.
Refer to the instructions for use for additional information: AEROECLIPSE* II BAN* Nebulizer, AEROECLIPSE* XL BAN* Nebulizer
‡ Bacteria load testing was not performed for these disinfection methods
‡‡ The high-level disinfection method outlined in the AEROECLIPSE* XL BAN* Nebulizer instructions for use has been validated according to DIN EN ISO 17665-1
† trade-marks of the respective companies
†† Meets US Cystic Fibrosis Foundation guidelines for cleaning and disinfection1
1. Lisa Saiman, et al. Cystic Fibrosis Foundation Guideline. Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update. Infection Control and Hospital Epidemiology. 2014;35(S1):S1-S67.
Data and Efficacy
Scientific & Performance Evidence
Trudell Medical International has an enviable history of strong leadership in creating innovative medical devices that enhance the quality of life for people of all ages - all backed by science and clinical evidence.
Product Information
FAQs
With breath actuated delivery, aerosol is only produced during the inspiratory cycle. This means medication is not wasted between breaths or during breaks in treatment (for example to cough or have a conversation). This puts the patient in control of their aerosol treatment. Other nebulizers continuously produce aerosol regardless of whether the patient is inhaling, exhaling or resting, resulting in medication being lost to the air instead of delivered to the lungs.
The AEROECLIPSE* II BAN* Nebulizer only produces aerosol during inhalation, so treatment time is dependent on breathing pattern and also breaks taken during the treatment. The dose (or amount of medication) and the gas source used (for example, hospital wall air) are other factors that affect treatment time.
Nebulizer design and the dose or amount of medication it’s delivering affect treatment time. To keep treatment time consistent, it’s important to properly care for the nebulizer according to the device’s instructions for use.
The frequency of nebulizer treatments depends on the type and severity of the patient’s condition. A health care provider can determine what’s right for the patient.
Nebulizers are often selected for patients such as infants and small children. A health care provider can determine what’s right for the patient.
The number of nebulizer treatments depends on the type and severity of the patient’s condition. Treatments may be recommended once or twice to several times daily. A health care provider can determine what’s right for the patient.
The AEROECLIPSE* II BAN* Nebulizer is an innovative device that produces aerosol only during inhalation. Most other nebulizers continuously produce aerosol regardless of whether the patient is inhaling, exhaling or resting. As a result, a large portion of the prescribed medication in a continuous nebulizer is released to the environment and is not inhaled. Care providers and others in the immediate surroundings have the risk of inhaling potentially harmful aerosolized emissions.
The AEROECLIPSE* II BAN* Nebulizer allows the healthcare provider many treatment options that may include fewer or shorter treatment times, less medication put into the nebulizer, or running the AEROECLIPSE* II BAN* Nebulizer continuously.
The green feedback button on the top of the AEROECLIPSE* II BAN* Nebulizer lowers during inhalation indicating that aerosol is being produced. When the patient stops inhaling, the button returns back to its original position indicating aerosol production has stopped. This movement can help encourage the patient to take long, slow breaths.
Down Position: Lowers upon inhalation.
Up Position: Rises back to the original ‘up’ position at the end of inhalation or between breaths.
Yes, the mouthpiece on the AEROECLIPSE* II BAN* Nebulizer can be removed and replaced with a COMFORTSEAL* Mask. The silicone mask contours gently to the face, providing a secure and comfortable fit. COMFORTSEAL* Masks are available in small, medium and large sizes.
To use the AEROECLIPSE* II BAN* Nebulizer in breath actuated mode, move the mode selector on the top of the nebulizer to the breath actuated position (*). If there is a time when you would rather have a continuous mist, simply move the mode selector clockwise to the continuous mode position (**).
*Breath actuated position:
** Continuous mode position:
Yes, simply use the device in the continuous mode position. Simply move the mode selector clockwise to the continuous mode position (**).
** Continuous mode position:
The AEROECLIPSE* II BAN* Nebulizer should be replaced after 7 days of use.
We recommend cleaning the nebulizer (excluding tubing) after each use.
The nebulizer (excluding tubing) can be cleaned after each use.
- The mode selector should be in the breath actuated position (*).
- Remove the EZ TWIST Tubing from the bottom of the nebulizer.
- Unscrew and remove the nebulizer top.
- Shake out excess drug.
- Use any of the following methods to clean the nebulizer.
- Hand Washing: Soak the three parts in a mild solution of liquid dish detergent and lukewarm clean water for about 5 minutes. Agitate gently. Rinse thoroughly with clean water. Shake out excess water.
- Sterile Water: Thoroughly rinse the three parts in sterile water. Shake out excess water.
- Briefly connect the tubing to the bottom of the nebulizer cup and the compressed air supply to clear the air pathway.
- Allow the parts to air dry thoroughly before reassembling.
- Reattach the nebulizer top, making sure to line up the white cylinder with the stem of the nebulizer cup. Gently hand tighten until a stop is detected.
- Reattach the mouthpiece to the nebulizer with the exhalation valve facing down.
- After the nebulizer is fully dry and assembled, store in a clean plastic bag or container.
Refer to the instructions for use for additional information.
* Breath actuated position:
The nebulizer (excluding tubing) can be disinfected each day. First, follow the cleaning instructions. Do not reassemble the nebulizer. Soak the mouthpiece, nebulizer top and nebulizer cup in 70 % isopropyl alcohol for 5 minutes. Rinse the parts thoroughly with sterile water. Allow the parts to air dry thoroughly before reassembling. After the nebulizer is fully dry and assembled, store in a clean plastic bag or container.
Refer to the instructions for use for additional information.
No, the AEROECLIPSE* II BAN* Nebulizer cannot be sterilized. Do not autoclave.
You may notice condensation on the inside of the EZ TWIST Tubing. This is normal. To remove the condensation, simply connect one end of the tubing to the compressed air supply, and allow the air to run without the nebulizer attached. This will force air through the tubing, drying the inside. To clean the exterior, wipe with a damp cloth. Allow to air dry thoroughly.
Refer to the instructions for use for additional information.
Yes, a filter kit is available for use with AEROECLIPSE* BAN* Nebulizers. The filter kit filters fugitive emissions (aerosolized medication)1, viruses2 and bacteria2 from the patient's exhaled breath. It reduces exposure of healthcare providers to potentially harmful emissions. The filter kit is a single patient, single use accessory (use only once).
| Aerosol Performance: | |
| Aerosol Output1 of AEROECLIPSE* BAN* Nebulizer with Filter Kit compared to the BAN* Nebulizer alone | ≥ 90 % |
| Aerosolized Medication Emissions1 when assembled with AEROECLIPSE* BAN* Nebulizer | ≤ 1 % |
| Filtration Performance: | |
| Viral Filtration Efficiency2 | ≥ 99.99 % |
| Bacterial Filtration Efficiency2 | ≥ 99.999 % |
1. TMI, Data on file 30 August 2020.
2. Breathing Filter Product Report, 24 October 2020, on file TMI.
The AEROECLIPSE* II BAN* Nebulizer can be connected directly to the AEROBIKA* OPEP device for nebulizer therapy during inhalation with secretion mobilization during exhalation. To use, first remove the mouthpiece from the AEROECLIPSE* II BAN* Nebulizer. Then, attach the device to the nebulizer port of the AEROBIKA* OPEP device. No adaptor is required. A healthcare provider can advise which medication to use for combined treatments.
Methacholine Challenge Testing
How to use the AEROECLIPSE* II BAN* Nebulizer for MCT
The AEROECLIPSE* II BAN* Nebulizer can be used for methacholine challenge testing (MCT, also known as bronchoprovocation testing).1
2017 ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests recommends a “suitable nebulizer or dosimeter may be used, but the manufacturer must provide characterization of the device output and particle size to allow construction of a table of concentration–dose steps for the inhalation protocol”.2
Published Values for the AEROECLIPSE* II BAN* Nebulizer3†
- Rate of output = 2.70 ± 0.22 mg/min (@ 16 mg/mL)
- Respirable Fraction = 76% < 5 μm
† Flow Rate: 8 L/min @ 50 psi
Calculation of Delivered Dose for Methacholine
For 1 minute of tidal breathing using the AEROECLIPSE* II BAN* Nebulizer, the estimated delivered dose would be:
Example Calculation of Delivered Dose
To determine the dose for other dilutions, the estimated delivered dose in 1 minute would be:
Calculate Your Delivered Dose
Please note this is for guidance only and that individual institutions may decide to generate alternative protocols if they have data to support such approaches.
Methacholine Challenge Testing Reference Sheet
Download the AEROECLIPSE* II BAN* nebulizer Methacholine Challenge Testing Reference Sheet
A Practical Guide for Interpretation of ERS Guidelines for Methacholine Challenge Test
This abstract provides a practical example of how the methacholine challenge test could be performed using the breath actuated AEROECLIPSE* II BAN* Nebulizer.
1. J Suggett, M Nagel. A Practical Guide for Interpretation of ERS Guidelines for Methacholine Challenge Test. European Respiratory Journal 2018;52(62):5484.
2. ERS Technical Standard on Bronchial Challenge Testing: General Considerations and Performance of Methacholine Challenge Tests. AL Coates, J Wanger, DW Cockcroft, BH Culver and the Bronchoprovocation Testing Task Force: K-H Carlsen, Z Diamant, G Gauvreau, GL Hall, TS Hallstrand, I Horvath, FHC de Jongh, G Joos, DA Kaminsky, BL Laube, JD Leuppi, PJ Sterk. European Respiratory Journal 2017;49:1601526.
3. Allan L Coates, Kitty Leung, Sharon D Dell. Developing alternative delivery systems for methacholine challenge tests. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2014;27(1):66-70.
